CXCL12 and neoplasm: Although subcutaneous models do not capture the unique tumor microenvironmental and immunosuppressive signatures such as the excessive stromal presence of PDAC, using subcutaneous PDX model in this study is a compromise preliminary solution to the challenge of studying the role of CXCL12 signaling in PDAC.